Science on Target Blog Target ALS Thought Leadership Pioneering the Next Generation of ALS Therapeutics: Announcing the 2025 Novel Modalities Consortia GranteesREAD MORETofersen Shows Promising Results in SOD1 ALS Treatment—A New Hope for Genetic TherapiesREAD MOREDigital Biomarkers – An Opportunity to Overcome the Limits of Traditional Rating Scales?READ MOREResearchers Report on the Opposing Roles of p38α Phosphorylation and Protein Arginine Methyltransferase 1 (PRMT1) Methylation in TDP-43 ProteinopathyREAD MOREUpdates from our Research Cores: Expanding our Cellular Model ToolkitREAD MOREScience on Target: Target ALS Postmortem Tissue Core Facilitates Groundbreaking Research on SOD1 Protein AggregationREAD MORELoad MoreThe Innovation EcosystemBridging Worlds: Volkan Granit and the Unique Collaborative Spirit of Target ALSREAD MOREScience on Target March 2025 NewsletterREAD MOREPerseverance and Prevailing: A Seven-Year Journey in Neuroscientific InnovationREAD MOREFrom Paris, With Love for Science: Dr. Latouche’s Groundbreaking ALS ResearchREAD MOREMind the Gap: Sabine Liebscher is Connecting the Dots of ALSREAD MOREProgress and Impact: 2022 Basic Biology GrantsREAD MORELoad More
